by jlohrconsulting | Jul 30, 2025 | Uncategorized
BMC Public Health. 2025 Jul 29;25(1):2580. doi: 10.1186/s12889-025-23735-8. ABSTRACT BACKGROUND: While cannabis use is prevalent among people with HIV (PWH), factors associated with higher-risk use require further study. We examined factors (mental health,...
by jlohrconsulting | Jul 30, 2025 | Uncategorized
BMC Psychol. 2025 Jul 29;13(1):847. doi: 10.1186/s40359-025-03202-0. ABSTRACT BACKGROUND: Mobile phone addiction has become a pervasive behavioral issue among adolescents, closely associated with various psychological stressors. Bullying victimization-defined as...
by jlohrconsulting | Jul 30, 2025 | Uncategorized
Eat Weight Disord. 2025 Jul 29;30(1):58. doi: 10.1007/s40519-025-01771-y. ABSTRACT BACKGROUND: Fluoxetine remains the only pharmacological treatment approved for Bulimia Nervosa, and no other drugs have been approved for eating disorders (EDs). The rationale for...
by jlohrconsulting | Jul 29, 2025 | Uncategorized
J Am Geriatr Soc. 2025 Jul 29. doi: 10.1111/jgs.19620. Online ahead of print. ABSTRACT BACKGROUND: Older adults who are homebound, defined as individuals who rarely or never leave their homes without assistance, represent a vulnerable and growing population with...
by jlohrconsulting | Jul 29, 2025 | Uncategorized
J Med Chem. 2025 Jul 29. doi: 10.1021/acs.jmedchem.5c01750. Online ahead of print. ABSTRACT Major depressive disorder (MDD) remains a significant global health burden, and its current treatments are limited by the delayed onset of efficacy weeks after dosing. While...
Recent Comments